Showing 1541-1550 of 1970 results for "".
- What is Exosome Therapy? All Your Questions Answeredhttps://modernaesthetics.com/news/what-is-exosome-therapy-all-your-questions-answered/2473445/Exosomes are among today’s buzziest skincare ingredients, but what exactly are exosomes, how can you choose the best product to recommend to patients, and how can exosomes be used to complement in-office skin rejuvenation procedures? New York City dermatologist Marina I. Pere
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- Eyebrow Thickness? It’s in Your Geneshttps://modernaesthetics.com/news/eyebrow-thickness-its-in-your-genes/2473425/The first gene mapping study on eyebrow thickness in Europeans discovered three previously unreported genetic loci, suggesting that eyebrow appearance has partly the same and partly different underlying genes in people from different parts of the world. The study, conducted by the Inter
- FDA Approves Galderma's Restylane Eyelighthttps://modernaesthetics.com/news/fda-approves-galdermas-restylane-eyelight/2473423/The U.S. Food and Drug Administration (FDA) approved Restylane Eyelight, a hyaluronic acid (HA) dermal filler for the correction of undereye hollowing, in adults over the age of 21. Restylane Eyelight is formulated with NASHA Technology, which has a firm gel te
- BTL Takes on Music Festival Season With Emfesthttps://modernaesthetics.com/news/btl-takes-on-music-festival-season-with-emfest/2473422/BTL’s Emfest is coming to set to the Pasea Resort and Spa in Huntington Beach, Calif. The event, slated for Aug. 26, 2023, will feature a diverse lineup of music performances. In addition to the musical aspect, Emfest will provide a wide range of wellness activities and
- Microneedling Plus Cupping May Aid Skin Rejuvenationhttps://modernaesthetics.com/news/microneedling-plus-cupping-may-aid-skin-rejuvenation/2473420/Microneedling to induce collagen and cupping to increase tissue perfusion may have a synergistic effect on skin rejuvenation, according to an experimental study in the June issue of Plastic and Reconstructive Surgery. "Cupping therapy can be added to microneedling therap
- Sentient Introduces Tixel in the UShttps://modernaesthetics.com/news/sentient-introduces-tixel-in-the-us/2473416/Sentient is rolling out Sentient Tixel in the US. Sentient Tixel uses thermal-mechanical action technology to resurface skin. Tixel technology uniquely combines heat with the forward motion of a medical-grade titanium tip without the use of lasers, radiation, ultrasound, or needles.
- FDA Approves Skinvive by Juvéderm to Improve Skin Smoothness in Cheekshttps://modernaesthetics.com/news/fda-approves-skinvive-by-juvederm-to-improve-skin-smoothness-in-cheeks/2473415/The U.S. Food and Drug Administration gave its nod to Skinvive by Juvéderm to improve skin smoothness of the cheeks in adults over the age of 21. Skinvive by Juvéderm is the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin smoothness availabl
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo